文献速递临床试验与 GCP

氨甲环酸预防性给药能否减少机器人辅助根治性前列腺切除术后的失血?RARPEX随机对照试验研究方案

Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2022-06-18

本研究为前瞻性、双盲、随机对照试验,旨在评估氨甲环酸预防性给药对机器人辅助根治性前列腺切除术围术期及术后失血(血红蛋白下降水平)的影响,并分析其对术后并发症发生率及严重程度的影响以确认安全性。研究基于前期预试验结果设计,目前尚无研究在机器人辅助根治性前列腺切除术开始时测试氨甲环酸的预防性给药。

要点

  • 前期预试验结果支持开展本项前瞻性、双盲、随机对照试验以确认初步数据。
  • 主要终点为氨甲环酸对机器人辅助根治性前列腺切除术围术期及术后失血(血红蛋白下降水平)的影响。
  • 次要终点为氨甲环酸对术后并发症的影响及在机器人辅助根治性前列腺切除术中的安全性。

核心结论

  • 本研究旨在回答预防性给予氨甲环酸是否可降低机器人辅助根治性前列腺切除术后的失血,或增加并发症的发生率及严重程度。

研究设计与样本

  • 前瞻性、双盲、随机对照试验,基于本团队预试验结果设计,旨在确认初步数据。
  • 研究方案已在ClinicalTrials.gov注册,注册号为NCT04319614,注册日期为2020年3月25日。

主要发现

  • 原文未报告本研究的结果数据。

关键数值与推荐

  • 主要终点:分析氨甲环酸对机器人辅助根治性前列腺切除术围术期及术后失血(血红蛋白水平下降)的影响。
  • 附加终点:分析氨甲环酸对术后并发症的影响,并确认氨甲环酸在机器人辅助根治性前列腺切除术中的安全性。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prophylactic administration of tranexamic acid reduces blood loss during procedures at high risk of perioperative bleeding. Several studies in cardiac surgery and orthopedics confirmed this finding. The aim of this prospective, double-blind, randomized study is to evaluate the effect of tranexamic acid on peri-and postoperative blood loss and on the incidence and severity of complications. METHODS/DESIGN: Based on the results of our pilot study, we decided to conduct this prospective, double-blind, randomized trial to confirm the preliminary data. The primary endpoint is to analyze the effect of tranexamic acid on perioperative and postoperative blood loss (decrease in hemoglobin levels) in robotic-assisted radical prostatectomy. The additional endpoint is to analyze the effect of tranexamic acid on postoperative complications and confirm the safety of tranexamic acid in robotic-assisted radical prostatectomy. DISCUSSION: No study to date has tested the prophylactic administration of tranexamic acid at the beginning of robotic-assisted radical prostatectomy. This study is designed to answer the question of whether the administration of tranexamic acid might lower the blood loss after the procedure or increase the rate and severity of complications. TRIAL REGISTRATION: ClinicalTrials.gov NCT04319614. Registered on 25 March 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Balik M, Kosina J, Husek P, et al. Can the prophylactic administration of tranexamic acid reduce the blood loss after robotic-assisted radical prostatectomy? Robotic Assisted Radical Prostatectomy with tranEXamic acid (RARPEX): study protocol for a randomized controlled trial. Trials. 2022. PMID: 35717263. doi:10.1186/s13063-022-06447-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。